Literature DB >> 12271004

Relapse of nephrotic syndrome triggered by biphosphonates.

Jon D Stratton, Paul Warwicker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12271004     DOI： 10.1093/ndt/17.10.1856-a

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis.

Authors:  M Yilmaz; H Taninmis; E Kara; A Ozagari; A Unsal
Journal:  Osteoporos Int       Date:  2012-01-26       Impact factor: 4.507

2.  Alendronate associated focal segmental glomerulosclerosis: a case report and review of the literature.

Authors:  Pranav S Garimella; Helmut G Rennke; James A Strom
Journal:  CEN Case Rep       Date:  2015-04-01

3.  Massive proteinuria and acute renal failure after oral bisphosphonate (alendronate) administration in a patient with focal segmental glomerulosclerosis.

Authors:  Naoto Miura; Natsuko Mizuno; Ryuhei Aoyama; Wataru Kitagawa; Harutaka Yamada; Kazuhiro Nishikawa; Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2008-08-28       Impact factor: 2.801

Review 4.  Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature.

Authors:  Ning Jia; Fionnuala C Cormack; Bin Xie; Zita Shiue; Behzad Najafian; Julie R Gralow
Journal:  BMC Cancer       Date:  2015-07-22       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.